CY2100B1 - Compounds for treating inflammatory bowel disease - Google Patents
Compounds for treating inflammatory bowel diseaseInfo
- Publication number
- CY2100B1 CY2100B1 CY9800024A CY9800024A CY2100B1 CY 2100 B1 CY2100 B1 CY 2100B1 CY 9800024 A CY9800024 A CY 9800024A CY 9800024 A CY9800024 A CY 9800024A CY 2100 B1 CY2100 B1 CY 2100B1
- Authority
- CY
- Cyprus
- Prior art keywords
- inflammatory bowel
- bowel disease
- treating inflammatory
- compounds
- benzyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/36—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Eye Examination Apparatus (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Nonmetallic Welding Materials (AREA)
- Surgical Instruments (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45420389A | 1989-12-21 | 1989-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
CY2100B1 true CY2100B1 (en) | 2002-04-05 |
Family
ID=23803709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY9800024A CY2100B1 (en) | 1989-12-21 | 1998-09-07 | Compounds for treating inflammatory bowel disease |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0434394B1 (xx) |
JP (1) | JP3036853B2 (xx) |
KR (1) | KR0176243B1 (xx) |
CN (1) | CN1029846C (xx) |
AT (1) | ATE169294T1 (xx) |
AU (1) | AU639734B2 (xx) |
CA (1) | CA2032330C (xx) |
CY (1) | CY2100B1 (xx) |
DE (1) | DE69032537T2 (xx) |
DK (1) | DK0434394T3 (xx) |
ES (1) | ES2121748T3 (xx) |
FI (2) | FI104251B (xx) |
HU (1) | HU216732B (xx) |
IE (1) | IE904633A1 (xx) |
IL (3) | IL108962A (xx) |
MX (1) | MX23803A (xx) |
NO (1) | NO300458B1 (xx) |
NZ (1) | NZ236472A (xx) |
PT (1) | PT96198B (xx) |
RU (2) | RU2036915C1 (xx) |
YU (1) | YU240690A (xx) |
ZA (1) | ZA9010041B (xx) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU87339A1 (fr) * | 1988-09-20 | 1990-04-06 | Oreal | Nouveaux derives de benzylidene-cyclanones,leur procede de preparation,leur utilisation en tant qu'agents anti-oxydants et comme filtres solaires,compositions cosmetiques et pharmaceutiques les contenant |
US5143928A (en) * | 1990-03-27 | 1992-09-01 | Warner-Lambert Company | 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents |
CZ181493A3 (en) * | 1992-09-10 | 1994-03-16 | Lilly Co Eli | The use of rhodanine derivative for the preparation of a pharmaceutical composition reducing level of sugar in blood and for treating alzheimer's disease |
ATE135697T1 (de) * | 1992-10-28 | 1996-04-15 | Shionogi & Co | Benzylidenderivate |
US6251928B1 (en) | 1994-03-16 | 2001-06-26 | Eli Lilly And Company | Treatment of alzheimer's disease employing inhibitors of cathepsin D |
US5563277A (en) * | 1994-12-21 | 1996-10-08 | Eli Lilly And Company | Process for preparing benzyl-substituted rhodanine derivatives |
ATE198476T1 (de) * | 1995-09-07 | 2001-01-15 | Lilly Co Eli | Alternative kristallform von tazofelon ((+,-)-5- ((3,5-bis(1,1-dimethylethyl)-4- hydroxyphenyl)methyl)-4-thiazolidinon) |
ES2146837T3 (es) * | 1995-09-07 | 2000-08-16 | Lilly Co Eli | Procedimiento para preparar derivados de la rodanina sustituidos con bencilo. |
EP0779282A1 (en) * | 1995-12-14 | 1997-06-18 | Eli Lilly And Company | Thiomorpholinone compounds for treating multiple sclerosis |
US5981523A (en) * | 1996-02-05 | 1999-11-09 | Eli Lilly And Company | Compounds and methods for treating multiple sclerosis |
US6063799A (en) * | 1996-09-03 | 2000-05-16 | Eli Lilly And Company | Alternate crystal form of Tazofelone |
US6005142A (en) | 1996-09-03 | 1999-12-21 | Eli Lilly And Company | Process for preparing benzyl-substituted rhodanine derivatives |
US6673816B1 (en) | 1998-09-30 | 2004-01-06 | Angelika Esswein | Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders |
AU6330999A (en) * | 1998-09-30 | 2000-04-17 | Roche Diagnostics Gmbh | Rhodanine derivatives for the treatment and prevention of metabolic bone disorders |
AU6331099A (en) * | 1998-09-30 | 2000-04-17 | Roche Diagnostics Gmbh | Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders |
US7235573B2 (en) | 2002-09-30 | 2007-06-26 | The Regents Of The University Of California | Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors |
EP1549321A4 (en) * | 2002-09-30 | 2007-05-23 | Univ California | HEMMER OF THE CFTR PROTEIN (CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE) AND ITS USES |
AU2002953533A0 (en) * | 2002-12-24 | 2003-01-16 | Arthron Limited | Fc receptor modulating compounds and compositions |
CN102844286B (zh) * | 2010-04-15 | 2014-12-31 | 默克专利股份有限公司 | 制备氢醌的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1285572C (en) * | 1985-08-09 | 1991-07-02 | Jill Ann Panetta | Di-t-butylphenol compounds |
IE940525L (en) * | 1988-05-25 | 1989-11-25 | Warner Lambert Co | Known and selected novel arylmethylenyl derivatives of¹thiazolidinones, imidazolidinones and oxazolidinones useful¹as antiallergy agents and antiinflammatory agents |
DE69027472T2 (de) * | 1989-04-07 | 1996-12-05 | Lilly Co Eli | Arylsubstituierte Rhodaninderivate |
-
1990
- 1990-12-13 IL IL10896290A patent/IL108962A/en not_active IP Right Cessation
- 1990-12-13 IL IL9665490A patent/IL96654A/en not_active IP Right Cessation
- 1990-12-13 ZA ZA9010041A patent/ZA9010041B/xx unknown
- 1990-12-14 CA CA002032330A patent/CA2032330C/en not_active Expired - Fee Related
- 1990-12-14 PT PT96198A patent/PT96198B/pt active IP Right Grant
- 1990-12-14 NZ NZ236472A patent/NZ236472A/xx unknown
- 1990-12-19 EP EP90313923A patent/EP0434394B1/en not_active Expired - Lifetime
- 1990-12-19 ES ES90313923T patent/ES2121748T3/es not_active Expired - Lifetime
- 1990-12-19 DK DK90313923T patent/DK0434394T3/da active
- 1990-12-19 KR KR1019900021001A patent/KR0176243B1/ko not_active IP Right Cessation
- 1990-12-19 NO NO905478A patent/NO300458B1/no not_active IP Right Cessation
- 1990-12-19 AT AT90313923T patent/ATE169294T1/de not_active IP Right Cessation
- 1990-12-19 AU AU68266/90A patent/AU639734B2/en not_active Ceased
- 1990-12-19 DE DE69032537T patent/DE69032537T2/de not_active Expired - Fee Related
- 1990-12-19 FI FI906273A patent/FI104251B/fi not_active IP Right Cessation
- 1990-12-19 MX MX2380390A patent/MX23803A/es unknown
- 1990-12-20 YU YU240690A patent/YU240690A/sh unknown
- 1990-12-20 IE IE463390A patent/IE904633A1/en not_active Application Discontinuation
- 1990-12-20 JP JP2413313A patent/JP3036853B2/ja not_active Expired - Fee Related
- 1990-12-20 HU HU908368A patent/HU216732B/hu not_active IP Right Cessation
- 1990-12-20 CN CN90109846A patent/CN1029846C/zh not_active Expired - Fee Related
- 1990-12-20 RU SU904894177A patent/RU2036915C1/ru active
-
1991
- 1991-12-24 RU SU915010352A patent/RU2050355C1/ru active
-
1994
- 1994-03-14 IL IL10896294A patent/IL108962A0/xx unknown
-
1998
- 1998-09-07 CY CY9800024A patent/CY2100B1/xx unknown
-
1999
- 1999-08-10 FI FI991698A patent/FI19991698A/fi unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA9010041B (en) | Compounds for treating inflammatory bowel disease | |
AU643489B2 (en) | Antibacterial agents - II | |
HUT56356A (en) | Process for producing thiazolidin-4-ones and 1,3-oxathiolan-5-one derivatives | |
GB2241509B (en) | Process for the sintered-metal production of moulded parts from intermetallic compounds | |
PT97547A (pt) | Processo para a preparacao de novas pirido {2,3-f}{1,4}tiazepinas e pirido {3,2-b}{1,5}benzotiazepinas e de composicoes farmaceuticas que as contem | |
DZ1335A1 (fr) | Procédé stéréospecifique pour la préparation des énantiomères de la furo (3,4-c) pyridine et composéainsi obtenus. | |
AU8204091A (en) | Process for producing enantiomers of 2-aryl-alkanoic acids | |
EP0443406A3 (en) | Process for enzymatic racemate separation of pantolacton | |
AU2048088A (en) | Process for polymorphic crystalline form conversion of buspirone hydrochloride | |
EP0799215A4 (en) | PROCESS FOR THE PREPARATION OF BENZYL-SUBSTITUTED RHODANINE DERIVATIVES | |
HUT63621A (en) | Process for producing new oxazolidine derivatives | |
HUT56344A (en) | Process for producing 2,4,5-tribromopyrrol-3-carbonitrile derivatives | |
CS53688A2 (en) | Method of new substituted 3-phenyl-7h-thiazolo/3,2-b//1,2,4/triazine -7-ons production | |
HU908032D0 (en) | Process for producing new sulfatic derivatives of galactane extracted from klebsiella | |
HU63191D0 (en) | Hexahydrobenz(c,d)indole derivatives and process for producing them | |
HU9203625D0 (en) | Stereoselective process for producing optical isomers of 1-benzoyl-4-hydroxi-5-(1-phenyl-ethyl)-amino-1,2,2a,3,4,5-hexahydrobenz/cd/-indole | |
PL325473A1 (en) | Method of obtaining benzyl-substituted derivatives of rhodanine | |
HUT60324A (en) | Process for producing compositions of yeast biomass base | |
CS21588A2 (en) | Process for preparing new derivative of 1h,3h-pyrrolo-/1,2-c/thiazole |